Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma

Overview of attention for article published in OncoTargets and therapy, June 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 747 followers.

Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma. https://t.co/qoPgXoYt4q

Reply Repost Favourite